A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer.
Saved in:
| Title: | A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer. |
|---|---|
| Authors: | Hashimoto T; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Takayanagi D; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Medicine, Division of Medical Oncology, Showa University School of Medicine, Tokyo, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Yonemaru J; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Naka T; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Nagashima K; Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan., Machida E; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Yatabe Y; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan., Kanemitsu Y; Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan., Hamamoto R; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan., Takashima A; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan., Sekine S; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan. ssekine@ncc.go.jp.; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan. ssekine@ncc.go.jp. |
| Source: | British journal of cancer [Br J Cancer] 2023 Oct; Vol. 129 (7), pp. 1176-1183. Date of Electronic Publication: 2023 Aug 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37543670 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hashimoto+T%22">Hashimoto T</searchLink>; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takayanagi+D%22">Takayanagi D</searchLink>; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Medicine, Division of Medical Oncology, Showa University School of Medicine, Tokyo, Japan.; Department of Clinical Diagnostic Oncology, Clinical Research Institute for Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yonemaru+J%22">Yonemaru J</searchLink>; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Naka+T%22">Naka T</searchLink>; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nagashima+K%22">Nagashima K</searchLink>; Biostatistics Unit, Clinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Machida+E%22">Machida E</searchLink>; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kohno+T%22">Kohno T</searchLink>; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yatabe+Y%22">Yatabe Y</searchLink>; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kanemitsu+Y%22">Kanemitsu Y</searchLink>; Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hamamoto+R%22">Hamamoto R</searchLink>; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takashima+A%22">Takashima A</searchLink>; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Shiraishi+K%22">Shiraishi K</searchLink>; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan.; Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sekine+S%22">Sekine S</searchLink>; Division of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan. ssekine@ncc.go.jp.; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan. ssekine@ncc.go.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2023 Oct; Vol. 129 (7), pp. 1176-1183. <i>Date of Electronic Publication: </i>2023 Aug 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37543670 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41416-023-02382-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1176 Titles: – TitleFull: A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hashimoto T – PersonEntity: Name: NameFull: Takayanagi D – PersonEntity: Name: NameFull: Yonemaru J – PersonEntity: Name: NameFull: Naka T – PersonEntity: Name: NameFull: Nagashima K – PersonEntity: Name: NameFull: Machida E – PersonEntity: Name: NameFull: Kohno T – PersonEntity: Name: NameFull: Yatabe Y – PersonEntity: Name: NameFull: Kanemitsu Y – PersonEntity: Name: NameFull: Hamamoto R – PersonEntity: Name: NameFull: Takashima A – PersonEntity: Name: NameFull: Shiraishi K – PersonEntity: Name: NameFull: Sekine S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2023 Oct Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1532-1827 Numbering: – Type: volume Value: 129 – Type: issue Value: 7 Titles: – TitleFull: British journal of cancer Type: main |
| ResultId | 1 |